Elbit Imaging Ltd. (EMITF)
USD 1.2
(0.0%)
USD 1.2
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 328 Thousand ILS | 0.0% |
| 2022 | - ILS | 0.0% |
| 2021 | - ILS | 0.0% |
| 2020 | - ILS | 0.0% |
| 2019 | - ILS | 0.0% |
| 2018 | - ILS | -100.0% |
| 2017 | 782.82 Million ILS | 198.95% |
| 2016 | 261.85 Million ILS | -24.75% |
| 2015 | 347.96 Million ILS | -12.7% |
| 2014 | 398.57 Million ILS | 10.53% |
| 2013 | 360.59 Million ILS | -46.27% |
| 2012 | 671.08 Million ILS | -33.64% |
| 2011 | 1.01 Billion ILS | -31.38% |
| 2010 | 1.47 Billion ILS | 112.54% |
| 2009 | 693.37 Million ILS | -36.87% |
| 2008 | 1.09 Billion ILS | -68.69% |
| 2007 | 3.5 Billion ILS | 110.58% |
| 2006 | 1.66 Billion ILS | 104.06% |
| 2005 | 816.22 Million ILS | 38.67% |
| 2004 | 588.62 Million ILS | 7.51% |
| 2003 | 547.5 Million ILS | 9.93% |
| 2002 | 498.04 Million ILS | -22.6% |
| 2001 | 643.43 Million ILS | 27.21% |
| 2000 | 505.79 Million ILS | 51.04% |
| 1999 | 334.88 Million ILS | 80390.68% |
| 1998 | 416.05 Thousand ILS | -99.98% |
| 1997 | 1.74 Billion ILS | 2.32% |
| 1996 | 1.7 Billion ILS | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | - ILS | 0.0% |
| 2024 Q1 | - ILS | -100.0% |
| 2023 FY | 328 Thousand ILS | 0.0% |
| 2023 Q2 | - ILS | 0.0% |
| 2023 Q1 | - ILS | 0.0% |
| 2023 Q4 | 164 Thousand ILS | 0.0% |
| 2023 Q3 | 164 Thousand ILS | 0.0% |
| 2022 FY | - ILS | 0.0% |
| 2022 Q1 | - ILS | 0.0% |
| 2022 Q4 | - ILS | 0.0% |
| 2022 Q3 | - ILS | 0.0% |
| 2022 Q2 | - ILS | 0.0% |
| 2021 Q4 | - ILS | 0.0% |
| 2021 Q1 | - ILS | 0.0% |
| 2021 Q3 | - ILS | 0.0% |
| 2021 Q2 | - ILS | 0.0% |
| 2021 FY | - ILS | 0.0% |
| 2020 Q1 | - ILS | 0.0% |
| 2020 Q4 | - ILS | 0.0% |
| 2020 FY | - ILS | 0.0% |
| 2020 Q3 | - ILS | 0.0% |
| 2020 Q2 | - ILS | 0.0% |
| 2019 Q3 | - ILS | 0.0% |
| 2019 Q1 | - ILS | 0.0% |
| 2019 Q2 | - ILS | 0.0% |
| 2019 Q4 | - ILS | 0.0% |
| 2019 FY | - ILS | 0.0% |
| 2018 Q2 | 473 Thousand ILS | 0.0% |
| 2018 Q1 | 473 Thousand ILS | 100.21% |
| 2018 FY | - ILS | -100.0% |
| 2018 Q4 | - ILS | 100.0% |
| 2018 Q3 | -856 Thousand ILS | -280.97% |
| 2017 FY | 782.82 Million ILS | 198.95% |
| 2017 Q4 | -225.01 Million ILS | 0.0% |
| 2017 Q1 | 225.01 Million ILS | 558.99% |
| 2017 Q2 | 225.01 Million ILS | 0.0% |
| 2017 Q3 | -225.01 Million ILS | -200.0% |
| 2016 Q3 | 44.56 Million ILS | -57.54% |
| 2016 Q4 | 34.14 Million ILS | -23.38% |
| 2016 FY | 261.85 Million ILS | -24.75% |
| 2016 Q1 | 78.17 Million ILS | 126.31% |
| 2016 Q2 | 104.97 Million ILS | 34.27% |
| 2015 FY | 347.96 Million ILS | -12.7% |
| 2015 Q3 | 31.3 Million ILS | -86.05% |
| 2015 Q2 | 224.43 Million ILS | 423.29% |
| 2015 Q4 | -297.15 Million ILS | -1049.28% |
| 2015 Q1 | 42.88 Million ILS | 109.39% |
| 2014 Q4 | -456.67 Million ILS | -264.02% |
| 2014 FY | 398.57 Million ILS | 10.53% |
| 2014 Q2 | 100.17 Million ILS | 27.56% |
| 2014 Q3 | 278.43 Million ILS | 177.95% |
| 2014 Q1 | 78.53 Million ILS | -22.3% |
| 2013 Q3 | 91.14 Million ILS | -0.4% |
| 2013 FY | 360.59 Million ILS | -46.27% |
| 2013 Q4 | 101.07 Million ILS | 10.89% |
| 2013 Q1 | 113.59 Million ILS | 284.6% |
| 2013 Q2 | 91.5 Million ILS | -19.44% |
| 2012 Q3 | 217.76 Million ILS | 150.75% |
| 2012 Q4 | -61.53 Million ILS | -128.26% |
| 2012 Q2 | 86.84 Million ILS | -79.23% |
| 2012 FY | 671.08 Million ILS | -33.64% |
| 2012 Q1 | 418.07 Million ILS | 43.59% |
| 2011 Q1 | 221.08 Million ILS | -55.79% |
| 2011 Q2 | 240.99 Million ILS | 9.01% |
| 2011 Q3 | 258.06 Million ILS | 7.08% |
| 2011 Q4 | 291.16 Million ILS | 12.83% |
| 2011 FY | 1.01 Billion ILS | -31.38% |
| 2010 Q4 | 500.1 Million ILS | 110.41% |
| 2010 FY | 1.47 Billion ILS | 112.54% |
| 2010 Q1 | 162.29 Million ILS | 4.49% |
| 2010 Q2 | 573.58 Million ILS | 253.41% |
| 2010 Q3 | 237.68 Million ILS | -58.56% |
| 2009 Q3 | 154.68 Million ILS | -7.67% |
| 2009 FY | 693.37 Million ILS | -36.87% |
| 2009 Q1 | 215.84 Million ILS | -15.43% |
| 2009 Q2 | 167.52 Million ILS | -22.39% |
| 2009 Q4 | 155.32 Million ILS | 0.42% |
| 2008 Q1 | 193.87 Million ILS | -91.48% |
| 2008 Q2 | 498.83 Million ILS | 157.3% |
| 2008 Q3 | 139.07 Million ILS | -72.12% |
| 2008 FY | 1.09 Billion ILS | -68.69% |
| 2008 Q4 | 255.22 Million ILS | 83.52% |
| 2007 Q4 | 2.27 Billion ILS | 535.92% |
| 2007 FY | 3.5 Billion ILS | 110.58% |
| 2007 Q3 | 357.62 Million ILS | 51.87% |
| 2007 Q2 | 235.47 Million ILS | -57.8% |
| 2007 Q1 | 557.97 Million ILS | -52.45% |
| 2006 Q1 | 171.96 Million ILS | -24.42% |
| 2006 FY | 1.66 Billion ILS | 104.06% |
| 2006 Q3 | 181.73 Million ILS | 20.63% |
| 2006 Q4 | 1.17 Billion ILS | 545.62% |
| 2006 Q2 | 150.65 Million ILS | -12.39% |
| 2005 FY | 816.22 Million ILS | 38.67% |
| 2005 Q2 | 144.4 Million ILS | 20.99% |
| 2005 Q1 | 119.35 Million ILS | -18.37% |
| 2005 Q4 | 227.52 Million ILS | -21.34% |
| 2005 Q3 | 289.26 Million ILS | 100.31% |
| 2004 Q1 | 156.52 Million ILS | -8.87% |
| 2004 Q2 | 172.44 Million ILS | 10.17% |
| 2004 Q3 | 113.52 Million ILS | -34.17% |
| 2004 Q4 | 146.21 Million ILS | 28.79% |
| 2004 FY | 588.62 Million ILS | 7.51% |
| 2003 FY | 547.5 Million ILS | 9.93% |
| 2003 Q3 | 154.19 Million ILS | 33.4% |
| 2003 Q1 | 119.05 Million ILS | -19.49% |
| 2003 Q2 | 115.58 Million ILS | -2.92% |
| 2003 Q4 | 171.75 Million ILS | 11.39% |
| 2002 Q4 | 147.88 Million ILS | 20.41% |
| 2002 Q1 | 185.5 Million ILS | 1.24% |
| 2002 Q2 | 237.64 Million ILS | 28.11% |
| 2002 FY | 498.04 Million ILS | -22.6% |
| 2002 Q3 | 122.82 Million ILS | -48.32% |
| 2001 Q2 | 148.11 Million ILS | 0.14% |
| 2001 FY | 643.43 Million ILS | 27.21% |
| 2001 Q4 | 183.22 Million ILS | 14.94% |
| 2001 Q3 | 159.4 Million ILS | 7.63% |
| 2001 Q1 | 147.89 Million ILS | -7.78% |
| 2000 Q2 | 124.25 Million ILS | 7.57% |
| 2000 Q1 | 115.5 Million ILS | 52.02% |
| 2000 Q3 | 106.18 Million ILS | -14.54% |
| 2000 FY | 505.79 Million ILS | 51.04% |
| 2000 Q4 | 160.37 Million ILS | 51.04% |
| 1999 Q3 | 86.3 Million ILS | 4.75% |
| 1999 Q2 | 82.38 Million ILS | 0.94% |
| 1999 Q1 | 81.62 Million ILS | 259018.16% |
| 1999 Q4 | 75.97 Million ILS | -11.96% |
| 1999 FY | 334.88 Million ILS | 80390.68% |
| 1998 Q2 | 367.05 Thousand ILS | 1.89% |
| 1998 FY | 416.05 Thousand ILS | -99.98% |
| 1998 Q1 | 360.25 Thousand ILS | -99.93% |
| 1998 Q4 | 31.5 Thousand ILS | -91.81% |
| 1998 Q3 | 384.55 Thousand ILS | 4.77% |
| 1997 FY | 1.74 Billion ILS | 2.32% |
| 1997 Q1 | 374.12 Million ILS | -27.66% |
| 1997 Q4 | 512.27 Million ILS | 25.83% |
| 1997 Q2 | 447.75 Million ILS | 19.68% |
| 1997 Q3 | 407.1 Million ILS | -9.08% |
| 1996 Q2 | 389.57 Million ILS | 3.18% |
| 1996 FY | 1.7 Billion ILS | 0.0% |
| 1996 Q3 | 411.81 Million ILS | 5.71% |
| 1996 Q1 | 377.58 Million ILS | 0.0% |
| 1996 Q4 | 517.15 Million ILS | 25.58% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AVITA Medical, Inc. | 50.56 Million USD | 99.351% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.958% |
| QHSLab, Inc. | 1.4 Million USD | 76.721% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.958% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 11.98 Million USD | 97.262% |
| Aurora Spine Corporation | 14.52 Million USD | 97.741% |
| BrainsWay Ltd. | 31.78 Million USD | 98.968% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | 54.107% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 99.521% |
| Vivos Inc. | 19.5 Thousand USD | -1582.051% |
| Kelyniam Global, Inc. | 2.67 Million USD | 87.726% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -61.007% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -278.709% |
| Avitar, Inc. | 3.1 Million USD | 89.441% |
| Nanomix Corporation | 15.45 Thousand USD | -2022.977% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 99.377% |
| Theraclion SA | 1.82 Million USD | 82.0% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 734.66 Thousand USD | 55.354% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | 75.682% |
| Lombard Medical, Inc. | 12.16 Million USD | 97.305% |
| ALR Technologies Inc. | 7468.00 USD | -4292.073% |
| Stratec SE | 289.14 Million USD | 99.887% |
| Vycor Medical, Inc. | 1.46 Million USD | 77.544% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.966% |
| VMS Rehab Systems, Inc. | 71.70 USD | -457361.646% |
| NewCardio, Inc. | 257.39 Thousand USD | -27.429% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -234.694% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | 54.487% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -288.239% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | 50.419% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 98.392% |
| IR-Med Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | 18.718% |
| Polarean Imaging plc | 890.93 Thousand USD | 63.185% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 88.472% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 88.358% |
| Urologix, Inc. | 14.23 Million USD | 97.696% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 90.069% |
| SS Innovations International, Inc. | 5.87 Million USD | 94.421% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -716.428% |
| Smith & Nephew plc | 5.68 Billion USD | 99.994% |
| NIOX Group Plc | 46.84 Million USD | 99.3% |
| Fuse Medical, Inc. | 16.11 Million USD | 97.965% |
| Broncus Holding Corporation | 10.25 Million USD | 96.802% |
| Brain Scientific Inc. | 214.56 Thousand USD | -52.868% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 83.416% |
| Health Logic Interactive Inc. | - USD | -Infinity% |